価格表
在庫・価格 : 2024年06月08日 18時37分 現在
商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
---|---|---|---|---|---|---|
Flk-1/Fc Chimera, Human, Recombinant <Vascular Endothelial Cell Growth Factor Receptor 2/Fc Chimera> <KDR> <VEGF Receptor 2> データシート |
357-KD-050 |
RSDアールアンドディー システムス R&D Systems, Inc. |
50 μg | ¥93,000 |
無 (未発注) |
追加 |
在庫・価格 : 2024年06月08日 18時37分 現在
使用文献
- No.: 1
-
文献情報:
Saaristo A et al. Lymphangiogenic gene therapy with minimal blood vascular side effects. J. Exp. Med. 2002 Sep;196(6):719-30
Saaristo A et al
2002/01/01
-
備考:
Application: Binding Assay, Sample Type: Cell Lysates -
参照:
- No.: 2
-
文献情報:
Orecchia A et al. Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the alpha 5 beta 1 integrin. J. Cell. Sci. 2003 Sep;116(Pt 17):3479-89
Orecchia A et al
2003/01/01
-
備考:
Species: Human, Application: Bioassay, Sample type: Whole Cells -
参照:
- No.: 3
-
文献情報:
Seo KH et al. Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation. Cancer Res. 2004 Sep;64(18):6482-8
Seo KH et al
2004/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 4
-
文献情報:
Woolard J et al. VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res. 2004 Nov;64(21):7822-35
Woolard J et al
2004/01/01
-
備考:
Application: Receptor Binding Assay, Sample Type: recombiant VEGF165,recombinant VEGF165b -
参照:
- No.: 5
-
文献情報:
Oliner J et al. Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. Cancer Cell 2004 Nov;6(5):507-16
Oliner J et al
2004/01/01
-
備考:
Application: Functional ELISA -
参照:
- No.: 6
-
文献情報:
Ozawa T et al. Erythroid cells play essential roles in angiogenesis by bone marrow cell implantation. J. Mol. Cell. Cardiol. 2006 May;40(5):629-38
Ozawa T et al
2006/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 7
-
文献情報:
Getmanova EV et al. Antagonists to human and mouse vascular endothelial growth factor receptor 2 generated by directed protein evolution in vitro. Chem. Biol. 2006 May;13(5):549-56
Getmanova EV et al
2006/01/01
-
備考:
Species: Human, Application: Biacore binding study, Sample type: recombinant VEGF -
参照:
- No.: 8
-
文献情報:
Ren WP et al. Association between UHMWPE particle-induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt-1 in vivo. Biomaterials 2006 Oct;27(30):5161-9
Ren WP et al
2006/01/01
-
備考:
Species: Mouse, Application: In Vivo, In Vivo -
参照:
- No.: 9
-
文献情報:
Lake AC et al. Low molecular weight fucoidan increases VEGF165-induced endothelial cell migration by enhancing VEGF165 binding to VEGFR-2 and NRP1. J. Biol. Chem. 2006 Dec;281(49):37844-52
Lake AC et al
2006/01/01
-
備考:
Application: Bioassay, Sample Type: Buffer -
参照:
- No.: 10
-
文献情報:
Backer MV et al. Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes. Nat. Med. 2007 Apr;13(4):504-9
Backer MV et al
2007/01/01
-
備考:
Species: Mouse, Application: In Vivo -
参照:
- No.: 11
-
文献情報:
Wirzenius M et al. Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. J. Exp. Med. 2007 Jun;204(6):1431-40
Wirzenius M et al
2007/01/01
-
備考:
Species: Porcine, Application: Bioassay, Sample type: Whole Cells -
参照:
- No.: 12
-
文献情報:
Pan Q et al. Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting. J. Biol. Chem. 2007 Aug;282(33):24049-56
Pan Q et al
2007/01/01
-
備考:
Species: Human, Application: Binding Assay, Sample type: recombinant VEGF -
参照:
- No.: 13
-
文献情報:
Krilleke D et al. Molecular mapping and functional characterization of the VEGF164 heparin-binding domain. J. Biol. Chem. 2007 Sep;282(38):28045-56
Krilleke D et al
2007/01/01
-
備考:
Application: Competitive Binding Assay -
参照:
- No.: 14
-
文献情報:
Gustafsdottir SM et al. Use of proximity ligation to screen for inhibitors of interactions between vascular endothelial growth factor A and its receptors. Clin. Chem. 2008 Jul;54(7):1218-25
Gustafsdottir SM et al
2008/01/01
-
備考:
Application: Bioassay -
参照:
- No.: 15
-
文献情報:
Ponticelli S et al. Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1. J. Biol. Chem. 2008 Dec;283(49):34250-9
Ponticelli S et al
2008/01/01
-
備考:
Application: Bioassay, Sample Type: Other: Tetrameric 4-23-5 Peptide -
参照:
- No.: 16
-
文献情報:
Rennel ES et al. VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo. Br. J. Cancer 2009 Oct;101(7):1183-93
Rennel ES et al
2009/01/01
-
備考:
Application: Bioassay, Sample Type: protein in buffer -
参照:
- No.: 17
-
文献情報:
Brookes K et al. Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs. Br. J. Cancer 2010 May;102(10):1524-32
Brookes K et al
2010/01/01
-
備考:
Application: Other: See notes, Sample Type: Plasma (EDTA) -
参照:
- No.: 18
-
文献情報:
Lorquet S et al. Soluble forms of VEGF receptor-1 and -2 promote vascular maturation via mural cell recruitment. FASEB J. 2010 Oct;24(10):3782-95
Lorquet S et al
2010/01/01
-
備考:
Application: Bioassay,IHC Fresh, Sample Type: Whole Cells -
参照:
- No.: 19
-
文献情報:
Nishiguchi KM et al. Regulation of pathologic retinal angiogenesis in mice and inhibition of VEGF-VEGFR2 binding by soluble heparan sulfate. PLoS ONE 2010;5(10):e13493
Nishiguchi KM et al
2010/01/01
-
備考:
Application: Bioassay, Sample Type: ocular fluid -
参照:
- No.: 20
-
文献情報:
Goyal A et al. Endorepellin, the angiostatic module of perlecan, interacts with both the ?2?1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonism. J. Biol. Chem. 2011 Jul;286(29):25947-62
Goyal A et al
2011/01/01
-
備考:
Application: Binding Competition, Sample Type: recombinant VEGFA and Endorepellin -
参照:
- No.: 21
-
文献情報:
Lorenzon E et al. MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway. Oncogene 2012 Jun;31(26):3136-47
Lorenzon E et al
2012/01/01
-
備考:
Application: Surface Plasmon Resonance, Sample Type: recombinanat VEGF165 -
参照:
- No.: 22
-
文献情報:
Pfister C et al. Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro. Br. J. Cancer 2012 Nov;107(10):1702-13
Pfister C et al
2012/01/01
-
備考:
Application: TaqMan Protein Assay Control, Sample Type: N/A -
参照:
- No.: 23
-
文献情報:
Harris NC et al. The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology. J. Biol. Chem. 2013 Mar;288(12):8176-86
Harris NC et al
2013/01/01
-
備考:
Application: Biosensor Analysis, Sample Type: peptides -
参照:
- No.: 24
-
文献情報:
Qi JH et al. Tissue inhibitor of metalloproteinases-3 peptides inhibit angiogenesis and choroidal neovascularization in mice. PLoS ONE 2013;8(3):e55667
Qi JH et al
2013/01/01
-
備考:
Application: Competitive ELISA, Sample Type: protein -
参照:
- No.: 25
-
文献情報:
Maertens L et al. Bone marrow-derived mesenchymal stem cells drive lymphangiogenesis. PLoS ONE 2014;9(9):e106976
Maertens L et al
2014/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 26
-
文献情報:
Kuchroo P et al. Paracrine factors secreted by umbilical cord-derived mesenchymal stem cells induce angiogenesis in vitro by a VEGF-independent pathway. Stem Cells Dev. 2015 Feb;24(4):437-50
Kuchroo P et al
2015/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照: